(Q61969270)
Statements
Open-Label, Multicenter, Multiple Oral Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents ≥10 to <18 Years of Age With Type 2 Diabetes Mellitus and Currently on a Stable Dose of Metformin (English)
0 references
March 2014
0 references
April 2016
0 references
17
0 references
10 year
0 references
17 year
0 references